WA
ACHV icon

Wasatch Advisors’s Achieve Life Sciences ACHV Stock Holding History

Wasatch Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-41
Closed -$206K – 373
2014
Q4 		$206K Hold
41
– – ﹤0.01% 372
2014
Q3 		$240K Sell
41
-1
-2% -$6.95K ﹤0.01% 384
2014
Q2 		$347K Sell
42
-64
-60% -$786K ﹤0.01% 383
2014
Q1 		$2.73M Buy
106
+39
+58% +$958K 0.03% 298
2013
Q4 		$1.23M Buy
67
+25
+60% +$439K 0.01% 347
2013
Q3 		$851K Buy
42
+11
+35% +$228K 0.01% 349
2013
Q2 		$670K Buy
+31
New +$693K 0.01% 364

Other funds holding ACHV

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Wasatch Advisors's ACHV Position: Q1 2015 in Review

Wasatch Advisors sold out of Achieve Life Sciences (ACHV) in Q1 2015, closing a stake of 41 shares — an estimated $206K sold.

Wasatch Advisors first reported a position in ACHV in Q2 2013 and held it in 7 quarters. The position peaked at $2.73M in Q1 2014. 49 funds tracked by Wall St. Rank hold ACHV as of Q1 2015.

  • Wasatch Advisors reported no remaining Achieve Life Sciences position as of Q1 2015 after selling out during the quarter.
  • Wasatch Advisors sold 41 Achieve Life Sciences shares in Q1 2015, an estimated $206K.
  • Wasatch Advisors first reported a position in Achieve Life Sciences in Q2 2013 and held it in 7 quarters.
  • Wasatch Advisors's Achieve Life Sciences position peaked at $2.73M in Q1 2014.
  • 49 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2015.

Based on Wasatch Advisors's 13F filing for Q1 2015, filed 14 May 2015.